The COVID-19 pandemic has functioned as both an acute stressor on abortion services and as a critical catalyst for innovations in medication abortion service delivery. Changes in clinical protocols and workflows have been made out of necessity in response to patient needs, workforce safety, and population health. At the same time, such changes have presented unexpected opportunities to test more streamlined and patient-centered service delivery models. These changes include reducing in-person clinical visits and shifts in screening, dispensing, and follow-up norms.
February 25, 2021